Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors

<b>Background.</b> Flaviviruses spread from endemic to non-endemic areas, causing illness in millions of people worldwide. The lack of effective therapies and the rapid expansion of flaviviral infections worldwide emphasize the importance of finding effective antivirals to treat such dis...

Full description

Saved in:
Bibliographic Details
Main Authors: Larisa Ivanova, Krystyna Naumenko, Margus Varjak, Sandra Koit, Yehudit Morozovsky, Andres Merits, Mati Karelson, Eva Zusinaite
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/3/283
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849343080789966848
author Larisa Ivanova
Krystyna Naumenko
Margus Varjak
Sandra Koit
Yehudit Morozovsky
Andres Merits
Mati Karelson
Eva Zusinaite
author_facet Larisa Ivanova
Krystyna Naumenko
Margus Varjak
Sandra Koit
Yehudit Morozovsky
Andres Merits
Mati Karelson
Eva Zusinaite
author_sort Larisa Ivanova
collection DOAJ
description <b>Background.</b> Flaviviruses spread from endemic to non-endemic areas, causing illness in millions of people worldwide. The lack of effective therapies and the rapid expansion of flaviviral infections worldwide emphasize the importance of finding effective antivirals to treat such diseases. <b>Objectives.</b> To find out the potential broad-spectrum flavivirus inhibitors among previously reported inhibitors of DENV2/DENV4. <b>Methods.</b> The cytotoxicity of compounds was tested using WST-1 assay. The compounds were tested for their ability to inhibit the infection of DENV2, ZIKV, KUNV, and TBEV, and the most active compounds were also analyzed using the replicon-based assay. Interactions of one of the identified inhibitors with possible viral targets were studied using molecular dynamics simulations. <b>Results.</b> Two out of eight previously reported DENV2/DENV4 inhibitors demonstrated the ability to inhibit all studied viruses at low micromolar concentrations. Compound <b>C6</b> demonstrated the ability to inhibit both DENV2 and TBEV. Compounds <b>C1</b> (lycorine), <b>C3</b> (mycophenolic acid), and <b>C7</b> (vidarabine) were demonstrated as inhibitors of TBEV infection for the first time. <b>Conclusions.</b> Several compounds, previously described as inhibitors of DENV, are also able to inhibit other flaviviruses. This work is the first report on the anti-TBEV activity of lycorine (<b>C1</b>) and mycophenolic acid (<b>C3</b>), as well as vidarabine (<b>C7</b>). In addition, this is the first experimental confirmation of the antiviral activity of compound <b>C5</b> and the lack of detectable antiviral activity of compound <b>C8,</b> demonstrating the necessity of experimental verification of the computational predictions.
format Article
id doaj-art-a1aec355c4244e6b878eddb7a6de0120
institution Kabale University
issn 1424-8247
language English
publishDate 2025-02-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-a1aec355c4244e6b878eddb7a6de01202025-08-20T03:43:10ZengMDPI AGPharmaceuticals1424-82472025-02-0118328310.3390/ph18030283Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus InhibitorsLarisa Ivanova0Krystyna Naumenko1Margus Varjak2Sandra Koit3Yehudit Morozovsky4Andres Merits5Mati Karelson6Eva Zusinaite7Institute of Chemistry, University of Tartu, Ravila 14A, 50411 Tartu, EstoniaInstitute of Bioengineering, University of Tartu, Nooruse 1, 50411 Tartu, EstoniaInstitute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, EstoniaInstitute of Bioengineering, University of Tartu, Nooruse 1, 50411 Tartu, EstoniaInstitute of Chemistry, University of Tartu, Ravila 14A, 50411 Tartu, EstoniaInstitute of Bioengineering, University of Tartu, Nooruse 1, 50411 Tartu, EstoniaInstitute of Chemistry, University of Tartu, Ravila 14A, 50411 Tartu, EstoniaInstitute of Bioengineering, University of Tartu, Nooruse 1, 50411 Tartu, Estonia<b>Background.</b> Flaviviruses spread from endemic to non-endemic areas, causing illness in millions of people worldwide. The lack of effective therapies and the rapid expansion of flaviviral infections worldwide emphasize the importance of finding effective antivirals to treat such diseases. <b>Objectives.</b> To find out the potential broad-spectrum flavivirus inhibitors among previously reported inhibitors of DENV2/DENV4. <b>Methods.</b> The cytotoxicity of compounds was tested using WST-1 assay. The compounds were tested for their ability to inhibit the infection of DENV2, ZIKV, KUNV, and TBEV, and the most active compounds were also analyzed using the replicon-based assay. Interactions of one of the identified inhibitors with possible viral targets were studied using molecular dynamics simulations. <b>Results.</b> Two out of eight previously reported DENV2/DENV4 inhibitors demonstrated the ability to inhibit all studied viruses at low micromolar concentrations. Compound <b>C6</b> demonstrated the ability to inhibit both DENV2 and TBEV. Compounds <b>C1</b> (lycorine), <b>C3</b> (mycophenolic acid), and <b>C7</b> (vidarabine) were demonstrated as inhibitors of TBEV infection for the first time. <b>Conclusions.</b> Several compounds, previously described as inhibitors of DENV, are also able to inhibit other flaviviruses. This work is the first report on the anti-TBEV activity of lycorine (<b>C1</b>) and mycophenolic acid (<b>C3</b>), as well as vidarabine (<b>C7</b>). In addition, this is the first experimental confirmation of the antiviral activity of compound <b>C5</b> and the lack of detectable antiviral activity of compound <b>C8,</b> demonstrating the necessity of experimental verification of the computational predictions.https://www.mdpi.com/1424-8247/18/3/283flavivirusesbroad-spectrum inhibitorsmolecular dynamics simulation
spellingShingle Larisa Ivanova
Krystyna Naumenko
Margus Varjak
Sandra Koit
Yehudit Morozovsky
Andres Merits
Mati Karelson
Eva Zusinaite
Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors
Pharmaceuticals
flaviviruses
broad-spectrum inhibitors
molecular dynamics simulation
title Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors
title_full Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors
title_fullStr Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors
title_full_unstemmed Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors
title_short Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors
title_sort dengue virus inhibitors as potential broad spectrum flavivirus inhibitors
topic flaviviruses
broad-spectrum inhibitors
molecular dynamics simulation
url https://www.mdpi.com/1424-8247/18/3/283
work_keys_str_mv AT larisaivanova denguevirusinhibitorsaspotentialbroadspectrumflavivirusinhibitors
AT krystynanaumenko denguevirusinhibitorsaspotentialbroadspectrumflavivirusinhibitors
AT margusvarjak denguevirusinhibitorsaspotentialbroadspectrumflavivirusinhibitors
AT sandrakoit denguevirusinhibitorsaspotentialbroadspectrumflavivirusinhibitors
AT yehuditmorozovsky denguevirusinhibitorsaspotentialbroadspectrumflavivirusinhibitors
AT andresmerits denguevirusinhibitorsaspotentialbroadspectrumflavivirusinhibitors
AT matikarelson denguevirusinhibitorsaspotentialbroadspectrumflavivirusinhibitors
AT evazusinaite denguevirusinhibitorsaspotentialbroadspectrumflavivirusinhibitors